According to MyMD Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -9,45ย โฌ. In 2022 the company made an earnings per share (EPS) of -9,96ย โฌ an increase over its 2021 EPS that were of -21,70ย โฌ.